Company Filing History:
Years Active: 2004
Title: Innovations in Vaccine Development by Lingling Zeng
Introduction
Lingling Zeng is an accomplished inventor based in Brooklyn, NY, known for her significant contributions to the field of vaccine development. With a focus on creating innovative solutions to combat viral infections, she has made strides in the research of flaviviruses, particularly dengue viruses.
Latest Patents
Zeng holds a patent for "Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines." This invention is directed toward vector stage replication-defective flaviviruses that are designed to limit viral reproduction in mosquito vectors. The mutant flaviviruses developed through her research may serve as effective vaccines, demonstrating a limited ability to replicate in the organisms that transmit flaviviruses to humans. The patent outlines methods for producing these mutant flaviviruses and inducing protective immunity against flavivirus infections in immunized subjects. Zeng's work is pivotal in advancing vaccine technology and public health.
Career Highlights
Lingling Zeng is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this prestigious institution allows her to collaborate with leading experts in the field and contribute to groundbreaking research in virology and immunology.
Collaborations
Zeng works alongside her colleague Lewis Markoff, contributing to a collaborative environment that fosters innovation and scientific discovery.
Conclusion
Lingling Zeng's innovative work in developing replication-defective dengue viruses represents a significant advancement in vaccine research. Her contributions are essential in the ongoing fight against viral diseases, showcasing the importance of scientific innovation in public health.